Significance of Preoperative Systemic Immune Score for Stage I Gastric Cancer Patients

Table 2

Patient baseline characteristics (adjuvant chemotherapy with surgery versus surgery alone).

Characteristics	AC group ()	Non-AC group ()	value
Age, years (median, IQR)	58 (18–81)	60 (20–93)	0.402
Sex			0.474
Male	103	692
Female	41	233
CEA level			0.146
Normal	112	759
Above normal	21	95
Unknown	11	71
CA 19–9 level			0.701
Normal	111	715
Above normal	22	130
Unknown	11	80
Differentiation
Well or moderate	78	525
Poor	66	400
Tumor size, cm			0.419
<3	84	506
≥3	60	419
Tumor location			0.591
Lower	76	519
Middle	20	118
Upper	31	176
Multiple	17	112
Type of surgery			0.522
Total gastrectomy	43	241
Subtotal gastrectomy	101	684
TNM stage			<0.001
IA	48	587
IB	96	338
Pretreatment dNLR			0.064
<2	116	681
≥2	28	244
Pretreatment hypoalbuminemia			0.260
No	121	774
Yes	23	151